Association between GSTT-1 gene deletion and the susceptibility to oral squamous cell carcinoma in cigarette-smoking subjects

被引:16
作者
Drummond, SN
Gomez, RS
Noronha, ACM
Pordeus, IA
Barbosa, AA
De Marco, L
机构
[1] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Pharmacol, BR-31270901 Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Dept Surg, BR-31270901 Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Dept Oral Pathol, BR-31270901 Belo Horizonte, MG, Brazil
关键词
oral squamous cells; carcinoma; polymorphism; GSTT1;
D O I
10.1016/j.oraloncology.2004.12.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oral squamous cell carcinoma (OSCC) is related to tobacco use and alcohol consumption and the individual susceptibility for development of this tumor has been associated with xenobiotic-metabolizing enzymes polymorphisms. Glutathione S-transferase Theta-1 (GSTT1) is a phase II metabolic enzyme that catalyzes detoxification reactions of carcinogenic compounds. A genetic polymorphism of the GSTT1 gene is characterized by a complete gene deletion and consequent absence of the enzyme. The null genotype (gene deleted) of GSTT1 has a decreased capacity in detoxifying carcinogens present in tobacco smoke, leading the formation of DNA-adducts and DNA damage. The purpose of the present study was to evaluate the association between GSTT1 polymorphism and risk for OSCC development in a Brazilian population. We investigated the GSTT1 polymorphism in 87 patients with OSCC and 81 age-sex matched controls. The genotypes were studied by PCR-based methods. Individuals homozygous for the wild type GSTT1 (+/+) and heterozygous (+/0) were grouped together. The prevalence of GSTT1 deficiency (null) was significantly higher in the group with OSSC patients with oral cancer of the floor of the mouth. The results suggest that GSTT1 polymorphism increases the risk for OSCC development. (c) 2005 Published by Elsevier Ltd.
引用
收藏
页码:515 / 519
页数:5
相关论文
共 24 条
[1]   Polymorphisms of xenobiotic metabolizing genes in oropharyngeal carcinoma [J].
Amador, AG ;
Righi, PD ;
Radpour, S ;
Everett, ET ;
Weisberger, E ;
Langer, M ;
Eckert, GJ ;
Christen, AG ;
Campbell, S ;
Summerlin, DJ ;
Reynolds, N ;
Hartsfield, JK .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 2002, 93 (04) :440-445
[2]  
AMORIM LMF, 2002, CANC LETT, V181, P179
[3]   HUMAN GLUTATHIONE S-TRANSFERASES [J].
AWASTHI, YC ;
SHARMA, R ;
SINGHAL, SS .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1994, 26 (03) :295-308
[4]   Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population [J].
Buch, SC ;
Notani, PN ;
Bhisey, RA .
CARCINOGENESIS, 2002, 23 (05) :803-807
[5]   Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma [J].
Casson, AG ;
Zheng, Z ;
Chiasson, D ;
MacDonald, K ;
Riddell, DC ;
Guernsey, JR ;
Guernsey, DL ;
McLaughlin, J .
CANCER DETECTION AND PREVENTION, 2003, 27 (02) :139-146
[6]   MTHFR C677T and A1298C polymorphisms:: Diet, estrogen, and risk of colon cancer [J].
Curtin, K ;
Bigler, J ;
Slattery, ML ;
Caan, B ;
Potter, JD ;
Ulrich, CM .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (02) :285-292
[7]   Expression of glutathione S-transferase α, P1-l and T1-1 in the human gastrointestinal tract [J].
de Bruin, WCC ;
Wagenmans, MJM ;
Peters, WHM .
JAPANESE JOURNAL OF CANCER RESEARCH, 2000, 91 (03) :310-316
[8]   GSTM1 polymorphism and oral squamous cell carcinoma [J].
Drummond, SN ;
De Marco, L ;
Noronha, JCM ;
Gomez, RS .
ORAL ONCOLOGY, 2004, 40 (01) :52-55
[9]  
Garte S, 2001, CANCER EPIDEM BIOMAR, V10, P1239
[10]   A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA [J].
Gemignani, F ;
Moreno, V ;
Landi, S ;
Moullan, N ;
Chabrier, A ;
Gutiérrez-Enríquez, S ;
Hall, J ;
Guino, E ;
Peinado, MA ;
Capella, G ;
Canzian, F .
ONCOGENE, 2004, 23 (10) :1954-1956